Okyo Pharma Ltd Stock Market Value
| OKYO Stock | USD 1.04 0.01 0.95% |
| Symbol | OKYO |
OKYO Pharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OKYO Pharma. If investors know OKYO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OKYO Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (2.92) | Return On Equity (29.69) |
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OKYO Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if OKYO Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OKYO Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
OKYO Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OKYO Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OKYO Pharma.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in OKYO Pharma on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding OKYO Pharma Ltd or generate 0.0% return on investment in OKYO Pharma over 30 days. OKYO Pharma is related to or competes with Candel Therapeutics, Anebulo Pharmaceuticals, Unicycive Therapeutics, Quoin Pharmaceuticals, Cardio Diagnostics, Virax Biolabs, and Senti Biosciences. OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering ... More
OKYO Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OKYO Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OKYO Pharma Ltd upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.85 | |||
| Information Ratio | 0.0061 | |||
| Maximum Drawdown | 32.59 | |||
| Value At Risk | (8.65) | |||
| Potential Upside | 14.55 |
OKYO Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OKYO Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OKYO Pharma's standard deviation. In reality, there are many statistical measures that can use OKYO Pharma historical prices to predict the future OKYO Pharma's volatility.| Risk Adjusted Performance | 0.0309 | |||
| Jensen Alpha | 0.1093 | |||
| Total Risk Alpha | (0.74) | |||
| Sortino Ratio | 0.0072 | |||
| Treynor Ratio | 0.4072 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OKYO Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
OKYO Pharma Backtested Returns
OKYO Pharma maintains Sharpe Ratio (i.e., Efficiency) of -0.0298, which implies the firm had a -0.0298% return per unit of standard deviation over the last 3 months. OKYO Pharma exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OKYO Pharma's Semi Deviation of 4.07, market risk adjusted performance of 0.4172, and Risk Adjusted Performance of 0.0309 to confirm the risk estimate we provide. The company holds a Beta of 0.38, which implies possible diversification benefits within a given portfolio. As returns on the market increase, OKYO Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding OKYO Pharma is expected to be smaller as well. At this point, OKYO Pharma has a negative expected return of -0.13%. Please make sure to check OKYO Pharma's treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day typical price , to decide if OKYO Pharma performance from the past will be repeated at some future point.
Auto-correlation | -0.18 |
Insignificant reverse predictability
OKYO Pharma Ltd has insignificant reverse predictability. Overlapping area represents the amount of predictability between OKYO Pharma time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OKYO Pharma price movement. The serial correlation of -0.18 indicates that over 18.0% of current OKYO Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
OKYO Pharma lagged returns against current returns
Autocorrelation, which is OKYO Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting OKYO Pharma's stock expected returns. We can calculate the autocorrelation of OKYO Pharma returns to help us make a trade decision. For example, suppose you find that OKYO Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
OKYO Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If OKYO Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if OKYO Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in OKYO Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
OKYO Pharma Lagged Returns
When evaluating OKYO Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of OKYO Pharma stock have on its future price. OKYO Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, OKYO Pharma autocorrelation shows the relationship between OKYO Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in OKYO Pharma Ltd.
Regressed Prices |
| Timeline |
Pair Trading with OKYO Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OKYO Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against OKYO Stock
The ability to find closely correlated positions to OKYO Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OKYO Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OKYO Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OKYO Pharma Ltd to buy it.
The correlation of OKYO Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OKYO Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OKYO Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OKYO Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out OKYO Pharma Correlation, OKYO Pharma Volatility and OKYO Pharma Alpha and Beta module to complement your research on OKYO Pharma. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
OKYO Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.